The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease
npj Aging and Mechanisms of Disease · 2015
DOI: 10.1038/npjamd.2015.8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift npj Aging and Mechanisms of Disease, 2015. Verfasst von Joshua S Talboom und 2 weiteren Autor:innen. Beteiligte Einrichtung: Banner Sun Health Research Institute, Sun City, AZ, USA. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Banner Sun Health Research Institute, Sun City, AZ, USA.
- Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, AZ, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Talboom, J. S., Velazquez, R., & Oddo, S. (2015). The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease. npj Aging and Mechanisms of Disease. https://doi.org/10.1038/npjamd.2015.8
Vancouver
Talboom JS, Velazquez R, Oddo S. The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease. npj Aging and Mechanisms of Disease. 2015. doi:10.1038/npjamd.2015.8
BibTeX
@article{Talboom2015,
author = {Talboom, Joshua S and Velazquez, Ramon and Oddo, Salvatore},
title = {The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease},
journal = {npj Aging and Mechanisms of Disease},
year = {2015},
doi = {10.1038/npjamd.2015.8}
}
EUVIMED